By Colin KellaherShares of Cano Health Inc. jumped nearly 10% Friday after Bloomberg reported that CVS Health Corp. is in exclusive talks to buy the operator of primary-care medical centers. Representatives for CVS and Cano declined to comment, according to the report. The Wall Street Journal last month had reported that Humana Inc. and CVS were circling Cano as healthcare heavyweights scramble to snap up primary-care providers. Analysts at Citi last month said a deal with Humana or CVS could value Cano at $14 share. Write to Colin Kellaher at colin.kellaher@wsj.com(END) Dow Jones NewswiresOctober 07, 2022 11:14 ET (15:14 GMT)Copyright (c) 2022 Dow Jones & Company, Inc.

Source: Wall Street Journal October 07, 2022 21:26 UTC